JP2014505679A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014505679A5 JP2014505679A5 JP2013546228A JP2013546228A JP2014505679A5 JP 2014505679 A5 JP2014505679 A5 JP 2014505679A5 JP 2013546228 A JP2013546228 A JP 2013546228A JP 2013546228 A JP2013546228 A JP 2013546228A JP 2014505679 A5 JP2014505679 A5 JP 2014505679A5
- Authority
- JP
- Japan
- Prior art keywords
- animal
- dgla
- composition
- probiotics
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 33
- 241001465754 Metazoa Species 0.000 claims 28
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 claims 17
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 claims 17
- 239000006041 probiotic Substances 0.000 claims 12
- 235000018291 probiotics Nutrition 0.000 claims 12
- 235000013305 food Nutrition 0.000 claims 9
- 235000015872 dietary supplement Nutrition 0.000 claims 6
- 230000032683 aging Effects 0.000 claims 3
- 210000001188 articular cartilage Anatomy 0.000 claims 3
- 230000007407 health benefit Effects 0.000 claims 3
- 201000008482 osteoarthritis Diseases 0.000 claims 3
- 235000013406 prebiotics Nutrition 0.000 claims 3
- 230000000529 probiotic effect Effects 0.000 claims 3
- 241000894007 species Species 0.000 claims 3
- 230000008355 cartilage degradation Effects 0.000 claims 2
- 230000037231 joint health Effects 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 239000000969 carrier Substances 0.000 claims 1
- 230000015556 catabolic process Effects 0.000 claims 1
- 238000006731 degradation reaction Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 238000012423 maintenance Methods 0.000 claims 1
- 239000002417 nutraceutical Substances 0.000 claims 1
- 235000021436 nutraceutical agent Nutrition 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061459902P | 2010-12-21 | 2010-12-21 | |
| US61/459,902 | 2010-12-21 | ||
| PCT/US2011/065173 WO2012087745A1 (en) | 2010-12-21 | 2011-12-15 | Methods and compositions for preventing and treating osteoarthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014505679A JP2014505679A (ja) | 2014-03-06 |
| JP2014505679A5 true JP2014505679A5 (enExample) | 2015-01-29 |
Family
ID=46314373
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013546228A Pending JP2014505679A (ja) | 2010-12-21 | 2011-12-15 | 変形性関節症の予防及び治療のための方法及び組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20140205569A1 (enExample) |
| EP (1) | EP2654744A4 (enExample) |
| JP (1) | JP2014505679A (enExample) |
| CN (1) | CN103384521A (enExample) |
| AU (1) | AU2011349718B2 (enExample) |
| BR (1) | BR112013018453A2 (enExample) |
| CA (1) | CA2822263A1 (enExample) |
| MX (1) | MX2013007191A (enExample) |
| RU (1) | RU2013133998A (enExample) |
| WO (1) | WO2012087745A1 (enExample) |
| ZA (1) | ZA201305497B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0907413D0 (en) | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
| US8293790B2 (en) | 2011-10-19 | 2012-10-23 | Dignity Sciences Limited | Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof |
| WO2014022816A2 (en) * | 2012-08-03 | 2014-02-06 | Dignity Sciences Limited | Pharmaceutical compositions comprising 15-hetre and methods of treating or preventing arthritis using same |
| MX375328B (es) | 2014-06-04 | 2025-03-06 | Ds Biopharma Ltd | Composiciones farmacéuticas que comprenden ácido dihomo-gamma-linolénico (dgla) y uso de las mismas |
| US20210315851A1 (en) | 2020-04-03 | 2021-10-14 | Afimmune Limited | Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE49783B1 (en) * | 1979-05-18 | 1985-12-11 | Efamol Ltd | Pharmaceutical and dietary composition comprising epsilon-linolenic acids |
| GB9403857D0 (en) * | 1994-03-01 | 1994-04-20 | Scotia Holdings Plc | Fatty acid derivatives |
| GB9403855D0 (en) * | 1994-03-01 | 1994-04-20 | Scotia Holdings Plc | Fatty acid derivatives |
| KR100490189B1 (ko) * | 1995-08-07 | 2005-05-17 | 산토리 가부시키가이샤 | 오메가 9계 불포화 지방산을 포함하는, 연골 조직의 이상에 기인하는 의학적 증상의 예방 또는 치료제 |
| GB9622636D0 (en) * | 1996-10-30 | 1997-01-08 | Scotia Holdings Plc | Presentation of bioactives |
| GB9710351D0 (en) * | 1997-05-20 | 1997-07-16 | Scotia Holdings Plc | Glucosamine fatty acids |
| PL207930B1 (pl) * | 2000-05-25 | 2011-02-28 | Nestle Sa | Zastosowanie wyizolowanego probiotycznego szczepu bakterii kwasu mlekowego o aktywności probiotycznej, kompozycja pokarmowa i izolowany szczep bakterii kwasu mlekowego |
| US20020188024A1 (en) * | 2000-08-23 | 2002-12-12 | Chilton Floyd H. | Fatty acid-containing emulsion with increased bioavailability |
| BRPI0413287A (pt) * | 2003-08-11 | 2006-10-10 | Hills Pet Nutrition Inc | métodos de restaurar uma função da articulação que é mais próxima do normal em um cão apresentando osteoartrite, e de eliminar a probabilidade de um cão desenvolver osteoartrite, e, uso de ácido eicosapentaenóico (epa) |
| US8633247B2 (en) * | 2003-08-11 | 2014-01-21 | Hill's Pet Nutrition, Inc. | Method for decreasing cartilage damage in dogs |
| WO2005053710A2 (en) * | 2003-11-21 | 2005-06-16 | Nestec S.A. | Food composition comprising glucosamine |
| RU2351153C2 (ru) * | 2004-07-01 | 2009-04-10 | Нестек С.А. | Композиция диеты при остеоартрите собак |
| EP3581178B1 (en) * | 2005-02-14 | 2023-08-30 | Suntory Holdings Limited | Composition containing dihomo-(gamma)-linolenic acid (dgla) as active ingredient |
| RU2008143294A (ru) * | 2006-04-03 | 2010-05-10 | Нестек С.А. (Ch) | Питательные композиции для стимуляции роста костей и поддержания здорового состояния костей и относящиеся к ним способы |
-
2011
- 2011-12-15 CN CN2011800680315A patent/CN103384521A/zh active Pending
- 2011-12-15 RU RU2013133998/15A patent/RU2013133998A/ru not_active Application Discontinuation
- 2011-12-15 US US13/996,225 patent/US20140205569A1/en not_active Abandoned
- 2011-12-15 AU AU2011349718A patent/AU2011349718B2/en not_active Ceased
- 2011-12-15 EP EP11850141.0A patent/EP2654744A4/en not_active Withdrawn
- 2011-12-15 CA CA2822263A patent/CA2822263A1/en not_active Abandoned
- 2011-12-15 BR BR112013018453A patent/BR112013018453A2/pt not_active IP Right Cessation
- 2011-12-15 MX MX2013007191A patent/MX2013007191A/es unknown
- 2011-12-15 JP JP2013546228A patent/JP2014505679A/ja active Pending
- 2011-12-15 WO PCT/US2011/065173 patent/WO2012087745A1/en not_active Ceased
-
2013
- 2013-07-19 ZA ZA2013/05497A patent/ZA201305497B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bottegoni et al. | Oral chondroprotection with nutraceuticals made of chondroitin sulphate plus glucosamine sulphate in osteoarthritis | |
| IN2012DN00760A (enExample) | ||
| MY153062A (en) | Methods of treating gastrointestinal disorders independent of the intake of food | |
| RU2012114786A (ru) | Питательные композиции, содержащие экзогенный витамин к2 | |
| MX2009009318A (es) | Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea. | |
| WO2011014255A8 (en) | Treatment of crohn's disease with laquinimod | |
| BR112014008044A2 (pt) | bactéria para uso como um probiótico para aplicações nutricionais e médicas | |
| JP2015523321A5 (enExample) | ||
| GB2503852A (en) | Compounds for the treatment of neuropsychiatric disorders | |
| PH12014502447A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| EA201000854A1 (ru) | Применение эдта и ее солей для профилактики и лечения дизентерии свиней и усиления эффектов антибиотиков, проявляющихся при этом заболевании | |
| WO2011002298A3 (en) | Animal feed or human food for improving intestinal barrier properties | |
| EA201100154A1 (ru) | Способ лечения заболеваний толстой кишки | |
| WO2021074649A3 (en) | Methods of promoting scfa production by gut microbiota | |
| RU2017122615A (ru) | Применение пробиотиков для усиления мужской фертильности | |
| RU2013133998A (ru) | Способы и композиции для предотвращения и лечения остеоартрита | |
| MX2013006353A (es) | Metodos y composiciones utiles para promover el sueño en animales. | |
| EP2575456A4 (en) | COMPOSITIONS AND METHODS FOR TREATING PRESENTATIONS | |
| JP2017061488A5 (enExample) | ||
| RU2008126860A (ru) | Способ повышения продуктивности и качества продукции овцеводства | |
| RU2013154564A (ru) | Способы и композиции для стимуляции роста безжировой массы тела | |
| WO2011133681A3 (en) | Low/high dose probiotic supplements and methods of their use | |
| CN106413743A (zh) | 用于关节炎、可动性和延缓衰老的组合物 | |
| WO2016008642A3 (en) | Compositions comprising cinnamaldehyde and zinc and methods of using such compositions | |
| UA94975C2 (ru) | Композиция и ее применение для лечения гипергликемии и связанных с ней болезней |